Top Industry Leaders in the Post Traumatic Stress Disorder Market
Latest Post-Traumatic Stress Disorder Companies UpdateJune 2023: Drugmaker Sanofi called the rival pharmaceutical company's court tab "improper" in a battle over the market for the EpiPen auto-injector device and requested a U.S. judge to limit Mylan's bid to collect legal costs in an antitrust complaint. In a petition in a federal court in Kansas, Sanofi's attorneys at Weil, Gotshal & Manges contended that most of Mylan's request for more than $776,000 in costs, including deposition fees and transcribing services, should be denied. After successfully fending Sanofi's accusations, Mylan—now a part of the Pennsylvania-based healthcare corporation Viatris—requests reimbursement for litigation expenditures. The disagreement will now be heard in federal court, according to the two companies, which claimed they could not agree over costs.List of Post-Traumatic Stress Disorder Key companies in the market
- Mylan NV (US)
- Greenstone LLC (US)
- Bionomics (Australia)
- Tonix Pharmaceuticals Holding Corp. (US)
- Marinus Pharmaceuticals Inc. (US)
- Azevan Pharmaceuticals (US)
- Lundbeck A/S (Denmark)
- Eli Lily and Company (US)
- Pfizer (US)
- GlaxoSmithKline (UK)